Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine

CompletedOBSERVATIONAL
Enrollment

1,470

Participants

Timeline

Start Date

March 22, 2016

Primary Completion Date

May 11, 2021

Study Completion Date

May 11, 2021

Conditions
Pregnancy
Interventions
DRUG

medical abortion

medical abortion

Trial Locations (17)

11435

Choices Women's Medical Center, Jamaica

20815

Carafem, Washington D.C.

Carafem, Chevy Chase

30309

Carafem, Atlanta

52245

Emma Goldman Clinic, Iowa City

55114

Planned Parenthood Minnesota, North Dakota, South Dakota, Saint Paul

59102

Planned Parenthood of Montana, Billings

60076

Carafem, Skokie

80207

Planned Parenthood of the Rocky Mountains, Denver

Planned Parenthood of the Rocky Mountains, New Mexico

96826

The University of Hawaii Women's Options Centers, Honolulu

97212

Planned Parenthood Columbia Willamette, Portland

Planned Parenthood Columbia Willamette, Washington

97239

Oregon Health and Sciences University Women's Health Research Unit, Portland

Oregon Health and Sciences University Women's Health Research Unit, Washington

04332

Maine Family Planning, Augusta

Maine Family Planning, New York

All Listed Sponsors
lead

Gynuity Health Projects

OTHER

NCT02513043 - Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine | Biotech Hunter | Biotech Hunter